Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
Top Story
•
April 18, 2026
•
0 Views
President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."
Source: https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
